Skip to main content

Biofluid Specificity of Long Non-Coding RNA Profile in Hypertension: Relevance of Exosomal Fraction.

Riffo-Campos AL, Perez-Hernandez J, Martinez-Arroyo O, Ortega A, Flores-Chova A, Redon J, Cortes R

Publication: Int J Mol Sci (2022) • Vol 23PMID: 35563588View on PubMed

Purpose

This paper compared differential expression of long non-coding RNA (lncRNA), PIWI-interacting RNA (piRNA), microRNA (miRNA), small nucleolar RNA (snoRNA), messenger RNA (mRNA), small nuclear RNA (snRNA), and small cajal body RNA (scaRNA) in exosomes and plasma from hypertensive patients with and without elevated urinary albumin excretion (UAE).

Conclusion

The most abundant RNA species in exosomes and plasma were piRNAs followed by miRNAs, mRNAs and lncRNAs. The most abundant noncoding RNA species with differential expression between hypertensive patients with and without UAE were lncRNAs (54%), followed by miRNAs (15%) and piRNAs (10%). Importantly, the number of differentially expressed noncoding RNAs between hypertensive patients with and without elevated UAE was higher when exosomes were used for the comparison than when plasma was used; the difference in number of differentially expressed lncRNAs between plasma and exosomes was significant.  Lists of differentially expressed lncRNAs, miRNAs, piRNAs and a combination of snoRNAs, snRNAs and scaRNAs showed little overlap between exosomes and plasma specimens. A higher percentage of IncRNAs, miRNAs, and piRNAs were differentially expressed (between patients with and without UAE)  in exosomes compared to plasma specimens; however, the number of combined snoRNAs, snRNAs, and scaRNAs that were differentially expressed was higher when plasma specimens were used than exosomes. Further analysis revealed another difference between exosome and plasma specimens, more differentially expressed IncRNAs were downregulated in exosomes compared to when plasma specimens were used.  While all 25 of the top differentially expressed lncRNAs identified in exosomes displayed a >2-fold difference between patients with and without UAE, only 10 of the 25 IncRNAs identified in plasma displayed a >2-fold difference. When targets of the differentially expressed IncRNAs were investigated, IncRNAs and one miRNA (miR-6820) were identified in both plasma and exosome specimens. Pathway analysis of the lncRNA targets in exosomes and plasma specimens showed enrichment of lncRNA in multiple pathways.

Studies (1)

Purpose

This study compared differential expression of lncRNA, piRNA, miRNA, snoRNA, mRNA, snRNA, and scaRNA in exosomes and plasma from hypertensive patients with and without elevated UAE. Blood was collected from 48 patients with hypertension, 26 of whom were normoalbuminuric and 22 had increased urinary albumin excretion (UAE).  Details regarding blood collection, including tube type and anticoagulant, were not provided.  Within 1 h of collection, plasma was separated by centrifugation (details not provided) and exosomes were isolated by sequential ultracentrifugation (2,250 g for 30 minutes, recentrifugation of the supernatant at 20,000 g for 45 min, then a third round of centrifugation at 110,000 g for an unspecified duration). The authors report that isolation of exosomes was confirmed by electron microscopy, Western blot and Tunable Resistive Pulse Sensing on a qNano Gold instrument, but no further details were provided. RNA was isolated from plasma using miRNeasy mini and from exosomes using the Total Exosome RNA and Protein Isolation Kit. RNA yield and integrity were measured using a Bioanalyzer. Sequencing libraries were constructed from exosome and plasma RNA using CleanTag Small RNA library preparation kit and sequenced on a HiSeq 2000 instrument.  Sequencing data was quality controlled using FASTQC v0.11.8, filtered using the FASTX-Toolkit v0.013 and aligned to the GENCODE human genome release 38 using STAR v2.7.3a. Data were analyzed using GenomicFeatures, Rsamtools, and GenomicAlignments Bioconductor packages. LncRNA targets were predicted using LncRRIsearch. Statistical comparisons between specimens from patients with and without increased UAE were made using the edgeR Bioconductor package using negative binomial generalized log-linear model and were adjusted using the Benjamini–Hochberg method.

Summary of Findings

The most abundant RNA species identified in exosomes and plasma were piRNA (42.05% and 51.12%, respectively) followed by miRNA (26.36% and 16.94%, respectively), mRNA (12.22% and 5.17%, respectively), and lncRNA (0.78% and 0.35%, respectively). The most abundant noncoding RNA species that were differentially expressed between hypertensive patients with and without increased UAE were lncRNAs (54%), followed by miRNAs (15%) and piRNAs (10%). Importantly, the number of differentially expressed noncoding RNAs between patients with and without increased UAE was higher in exosomes than plasma; but when broken down by subtype, the difference in percentages between exosomes and plasma was only significant for lncRNAs (58% in exosomes versus 47% in plasma, P<0.05).  Interestingly, differentially expressed lncRNAs showed little overlap between exosomes and plasma: 84% of differentially expressed lncRNAs between exosome specimens were not differentially expressed in plasma and 59% of differentially expressed lncRNA in plasma specimens were not differentially expressed in exosome specimens. Like lncRNAs, a higher percentage of miRNAs and piRNAs were differentially expressed only in exosomes (84.7% and 87%, respectively) compared to those that were differentially expressed only in plasma (74%, both); but, a higher combined number of snoRNAs, snRNA and scaRNA were found to be differentially expressed only in plasma specimens compared to those differentially expressed only in exosome specimens (69% versus 31%). Further analysis showed that 71% of the differentially expressed lncRNAs in exosomes of patients with increased UAE were downregulated while only 59% of the differentially expressed lncRNAs in plasma were downregulated. While all 25 of the top differentially expressed lncRNAs that were identified in exosomes displayed a >2-fold difference between patients with and without elevated UAE, only 10 of the 25 in plasma displayed a >2-fold difference. When targets of the differentially expressed IncRNAs were investigated, IncRNAs (26.4% of targets for plasma and 27.8% for exosomes) and one miRNA (miR-6820) were identified in both plasma and exosome specimens. Pathway analysis of targets of differentially expressed lncRNAs in exosomes showed enrichment of lncRNA in the “acyl CoA hydrolase, laminin binding, extracellular matrix binding, and ubiquitin-like protein-specific isopeptidase activity” pathways. Pathway analysis of targets of differentially expressed lncRNAs in plasma showed enrichment of lncRNA in the “structural molecule activity, histone binding, scaffold protein binding and p53 binding” pathways.

  • Biospecimens

    FluidBlood
    FluidPlasma
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Hypertension
  • Platforms

    RNANext generation sequencing
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Hypertension with elevated UAE
    Hypertension without elevated UAE
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Plasma exosomes